Related Experiment Videos
Suppressed bone induction by follistatin in spontaneously hypercholesterolemic rat bone
Life Sciences
|January 1, 1997
Summary
Younger rats exhibit lower bone induction due to higher follistatin levels in demineralized bone matrix (DBM). This bone-inducing protein interferes with cartilage and bone formation, impacting bone regeneration efficacy.
Area of Science:
- Biochemistry
- Orthopedics
- Regenerative Medicine
Background:
- Demineralized bone matrix (DBM) is used for bone regeneration.
- Bone-inducing activity varies with donor age.
- Follistatin is an activin-binding protein with potential roles in tissue development.
Purpose of the Study:
- To investigate the role of bone follistatin in age-related differences in bone induction.
- To determine if follistatin levels influence the efficacy of DBM in spontaneously hypercholesterolemic (SHC) rats.
Main Methods:
- Comparison of follistatin content in DBM from young (10-week-old) and aged (6-month-old) SHC rats.
- Implantation of DBM with and without follistatin supplementation.
- Quantification of bone formation markers (C-propeptide of type II procollagen, calcium content) at day 12 post-implantation.
Main Results:
- DBM from young rats (DBM-10wk) had higher follistatin levels than DBM from aged rats (DBM-6mo).
- Without supplementation, DBM-6mo showed significantly higher bone formation markers than DBM-10wk.
- Follistatin supplementation reduced bone formation markers in both DBM types, making them comparable.
Conclusions:
- Follistatin content in bone matrix decreases with age in SHC rats.
- Follistatin interferes with endochondral bone formation.
- Higher follistatin abundance in young SHC rat DBM contributes to its lower bone induction capacity.